Global Antiserum Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 23-Nov-2022
No. of pages: 111
Inquire Before Buying

Antiserum is human or nonhuman blood serum containing monoclonal or polyclonal antibodies that is used to spread passive immunity to many diseases.

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Antiserum estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

The USA market for Antiserum is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for Antiserum is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for Antiserum is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key manufacturers of Antiserum include Charles River, SSI Diagnostica, BD, GD Animal Health, Novacyt Group, OriGene Technologies, Bethyl Laboratories, FUJIFILM Wako Pure Chemical Corporation and Thermo Scientific, etc. In 2021, the global top five players had a share approximately % in terms of revenue.

In terms of production side, this report researches the Antiserum production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.

In terms of sales side, this report focuses on the sales of Antiserum by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.

Report Scope

This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Antiserum manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Antiserum market. Further, it explains the major drivers and regional dynamics of the global Antiserum market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Charles River

- SSI Diagnostica

- BD

- GD Animal Health

- Novacyt Group

- OriGene Technologies

- Bethyl Laboratories

- FUJIFILM Wako Pure Chemical Corporation

- Thermo Scientific

- Bio-Rad

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.

Antiserum Segment by Type

- Antitoxin Serum

- Antibacterial Serum

- Antiviral Serum

- Anti-Rh Serum

Antiserum Segment by Application

- Laboratory

- Clinical

- Other

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the Antiserum production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Antiserum market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Antiserum, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Antiserum, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Antiserum, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antiserum sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Antiserum market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Antiserum sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Charles River, SSI Diagnostica, BD, GD Animal Health, Novacyt Group, OriGene Technologies, Bethyl Laboratories, FUJIFILM Wako Pure Chemical Corporation and Thermo Scientific, etc.

Global Antiserum Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Antiserum Research Scope
1.2 Market Segment by Type
1.2.1 Global Antiserum Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Antitoxin Serum
1.2.3 Antibacterial Serum
1.2.4 Antiviral Serum
1.2.5 Anti-Rh Serum
1.3 Market Segment by Application
1.3.1 Global Antiserum Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Laboratory
1.3.3 Clinical
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Market Production
2.1 Global Antiserum Production Capacity (2017-2028)
2.2 Global Antiserum Production by Region: 2017 VS 2021 VS 2028
2.3 Global Antiserum Production by Region
2.3.1 Global Antiserum Historic Production by Region (2017-2022)
2.3.2 Global Antiserum Forecasted Production by Region (2023-2028)
2.3.3 North America
2.3.4 Europe
2.3.5 Japan
2.3.6 China
2.3.7 South Korea
2.3.8 India
2.4 Market Dynamics
2.4.1 Antiserum Industry Trends
2.4.2 Antiserum Market Drivers
2.4.3 Antiserum Market Challenges
2.4.4 Antiserum Market Restraints
3 Global Antiserum Sales
3.1 Global Antiserum Sales Estimates and Forecasts 2017-2028
3.2 Global Antiserum Revenue Estimates and Forecasts 2017-2028
3.3 Global Antiserum Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Top Antiserum Regions by Sales
3.4.1 Global Top Antiserum Regions by Sales (2017-2022)
3.4.2 Global Top Antiserum Regions by Sales (2023-2028)
3.5 Global Top Antiserum Regions by Revenue
3.5.1 Global Top Antiserum Regions by Revenue (2017-2022)
3.5.2 Global Top Antiserum Regions by Revenue (2023-2028)
3.5.3 North America
3.5.4 Europe
3.5.5 Asia-Pacific
3.5.6 Latin America
3.5.7 Middle East & Africa
4 Competition by Manufacturers
4.1 Global Antiserum Production Capacity by Manufacturers
4.2 Global Antiserum Sales by Manufacturers
4.2.1 Global Top Antiserum Manufacturers by Sales (2017-2022)
4.2.2 Global Top Antiserum Manufacturers Market Share by Sales (2017-2022)
4.2.3 Global Top 10 and Top 5 Companies by Antiserum Sales in 2021
4.3 Global Antiserum Revenue by Manufacturers
4.3.1 Global Top Antiserum Manufacturers by Revenue (2017-2022)
4.3.2 Global Top Antiserum Manufacturers Market Share by Revenue (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Antiserum Revenue in 2021
4.4 Global Antiserum Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Antiserum Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Antiserum Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Estimates and Forecasts by Type
5.1 Global Antiserum Sales by Type
5.1.1 Global Antiserum Historical Sales by Type (2017-2022)
5.1.2 Global Antiserum Forecasted Sales by Type (2023-2028)
5.1.3 Global Antiserum Sales Market Share by Type (2017-2028)
5.2 Global Antiserum Revenue by Type
5.2.1 Global Antiserum Historical Revenue by Type (2017-2022)
5.2.2 Global Antiserum Forecasted Revenue by Type (2023-2028)
5.2.3 Global Antiserum Revenue Market Share by Type (2017-2028)
5.3 Global Antiserum Price by Type
5.3.1 Global Antiserum Price by Type (2017-2022)
5.3.2 Global Antiserum Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Antiserum Sales by Application
6.1.1 Global Antiserum Historical Sales by Application (2017-2022)
6.1.2 Global Antiserum Forecasted Sales by Application (2023-2028)
6.1.3 Global Antiserum Sales Market Share by Application (2017-2028)
6.2 Global Antiserum Revenue by Application
6.2.1 Global Antiserum Historical Revenue by Application (2017-2022)
6.2.2 Global Antiserum Forecasted Revenue by Application (2023-2028)
6.2.3 Global Antiserum Revenue Market Share by Application (2017-2028)
6.3 Global Antiserum Price by Application
6.3.1 Global Antiserum Price by Application (2017-2022)
6.3.2 Global Antiserum Price Forecast by Application (2023-2028)
7 North America
7.1 North America Antiserum Sales Breakdown by Company
7.1.1 North America Antiserum Sales by Company (2017-2022)
7.1.2 North America Antiserum Revenue by Company (2017-2022)
7.2 North America Antiserum Market Size by Type
7.2.1 North America Antiserum Sales by Type (2017-2028)
7.2.2 North America Antiserum Revenue by Type (2017-2028)
7.3 North America Antiserum Market Size by Application
7.3.1 North America Antiserum Sales by Application (2017-2028)
7.3.2 North America Antiserum Revenue by Application (2017-2028)
7.4 North America Antiserum Market Size by Country
7.4.1 North America Antiserum Sales by Country (2017-2028)
7.4.2 North America Antiserum Revenue by Country (2017-2028)
7.4.3 U.S.
7.4.4 Canada
8 Europe
8.1 Europe Antiserum Sales Breakdown by Company
8.1.1 Europe Antiserum Sales by Company (2017-2022)
8.1.2 Europe Antiserum Revenue by Company (2017-2022)
8.2 Europe Antiserum Market Size by Type
8.2.1 Europe Antiserum Sales by Type (2017-2028)
8.2.2 Europe Antiserum Revenue by Type (2017-2028)
8.3 Europe Antiserum Market Size by Application
8.3.1 Europe Antiserum Sales by Application (2017-2028)
8.3.2 Europe Antiserum Revenue by Application (2017-2028)
8.4 Europe Antiserum Market Size by Country
8.4.1 Europe Antiserum Sales by Country (2017-2028)
8.4.2 Europe Antiserum Revenue by Country (2017-2028)
8.4.3 Germany
8.4.4 France
8.4.5 U.K.
8.4.6 Italy
8.4.7 Russia
9 Asia Pacific
9.1 Asia Pacific Antiserum Sales Breakdown by Company
9.1.1 Asia Pacific Antiserum Sales by Company (2017-2022)
9.1.2 Asia Pacific Antiserum Revenue by Company (2017-2022)
9.2 Asia Pacific Antiserum Market Size by Type
9.2.1 Asia Pacific Antiserum Sales by Type (2017-2028)
9.2.2 Asia Pacific Antiserum Revenue by Type (2017-2028)
9.3 Asia Pacific Antiserum Market Size by Application
9.3.1 Asia Pacific Antiserum Sales by Application (2017-2028)
9.3.2 Asia Pacific Antiserum Revenue by Application (2017-2028)
9.4 Asia Pacific Antiserum Market Size by Region
9.4.1 Asia Pacific Antiserum Sales by Region (2017-2028)
9.4.2 Asia Pacific Antiserum Revenue by Region (2017-2028)
9.4.3 China
9.4.4 Japan
9.4.5 South Korea
9.4.6 India
9.4.7 Australia
9.4.8 Taiwan
9.4.9 Indonesia
9.4.10 Thailand
9.4.11 Malaysia
9.4.12 Philippines
10 Latin America
10.1 Latin America Antiserum Sales Breakdown by Company
10.1.1 Latin America Antiserum Sales by Company (2017-2022)
10.1.2 Latin America Antiserum Revenue by Company (2017-2022)
10.2 Latin America Antiserum Market Size by Type
10.2.1 Latin America Antiserum Sales by Type (2017-2028)
10.2.2 Latin America Antiserum Revenue by Type (2017-2028)
10.3 Latin America Antiserum Market Size by Application
10.3.1 Latin America Antiserum Sales by Application (2017-2028)
10.3.2 Latin America Antiserum Revenue by Application (2017-2028)
10.4 Latin America Antiserum Market Size by Country
10.4.1 Latin America Antiserum Sales by Country (2017-2028)
10.4.2 Latin America Antiserum Revenue by Country (2017-2028)
10.4.3 Mexico
10.4.4 Brazil
10.4.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Antiserum Sales Breakdown by Company
11.1.1 Middle East and Africa Antiserum Sales by Company (2017-2022)
11.1.2 Middle East and Africa Antiserum Revenue by Company (2017-2022)
11.2 Middle East and Africa Antiserum Market Size by Type
11.2.1 Middle East and Africa Antiserum Sales by Type (2017-2028)
11.2.2 Middle East and Africa Antiserum Revenue by Type (2017-2028)
11.3 Middle East and Africa Antiserum Market Size by Application
11.3.1 Middle East and Africa Antiserum Sales by Application (2017-2028)
11.3.2 Middle East and Africa Antiserum Revenue by Application (2017-2028)
11.4 Middle East and Africa Antiserum Market Size by Country
11.4.1 Middle East and Africa Antiserum Sales by Country (2017-2028)
11.4.2 Middle East and Africa Antiserum Revenue by Country (2017-2028)
11.4.3 Turkey
11.4.4 Saudi Arabia
11.4.5 U.A.E
12 Company Profiles
12.1 Charles River
12.1.1 Charles River Corporation Information
12.1.2 Charles River Overview
12.1.3 Charles River Antiserum Sales, Revenue, Price and Gross Margin (2017-2022)
12.1.4 Charles River Antiserum Products and Services
12.1.5 Charles River Antiserum SWOT Analysis
12.1.6 Charles River Recent Developments
12.2 SSI Diagnostica
12.2.1 SSI Diagnostica Corporation Information
12.2.2 SSI Diagnostica Overview
12.2.3 SSI Diagnostica Antiserum Sales, Revenue, Price and Gross Margin (2017-2022)
12.2.4 SSI Diagnostica Antiserum Products and Services
12.2.5 SSI Diagnostica Antiserum SWOT Analysis
12.2.6 SSI Diagnostica Recent Developments
12.3 BD
12.3.1 BD Corporation Information
12.3.2 BD Overview
12.3.3 BD Antiserum Sales, Revenue, Price and Gross Margin (2017-2022)
12.3.4 BD Antiserum Products and Services
12.3.5 BD Antiserum SWOT Analysis
12.3.6 BD Recent Developments
12.4 GD Animal Health
12.4.1 GD Animal Health Corporation Information
12.4.2 GD Animal Health Overview
12.4.3 GD Animal Health Antiserum Sales, Revenue, Price and Gross Margin (2017-2022)
12.4.4 GD Animal Health Antiserum Products and Services
12.4.5 GD Animal Health Antiserum SWOT Analysis
12.4.6 GD Animal Health Recent Developments
12.5 Novacyt Group
12.5.1 Novacyt Group Corporation Information
12.5.2 Novacyt Group Overview
12.5.3 Novacyt Group Antiserum Sales, Revenue, Price and Gross Margin (2017-2022)
12.5.4 Novacyt Group Antiserum Products and Services
12.5.5 Novacyt Group Antiserum SWOT Analysis
12.5.6 Novacyt Group Recent Developments
12.6 OriGene Technologies
12.6.1 OriGene Technologies Corporation Information
12.6.2 OriGene Technologies Overview
12.6.3 OriGene Technologies Antiserum Sales, Revenue, Price and Gross Margin (2017-2022)
12.6.4 OriGene Technologies Antiserum Products and Services
12.6.5 OriGene Technologies Antiserum SWOT Analysis
12.6.6 OriGene Technologies Recent Developments
12.7 Bethyl Laboratories
12.7.1 Bethyl Laboratories Corporation Information
12.7.2 Bethyl Laboratories Overview
12.7.3 Bethyl Laboratories Antiserum Sales, Revenue, Price and Gross Margin (2017-2022)
12.7.4 Bethyl Laboratories Antiserum Products and Services
12.7.5 Bethyl Laboratories Antiserum SWOT Analysis
12.7.6 Bethyl Laboratories Recent Developments
12.8 FUJIFILM Wako Pure Chemical Corporation
12.8.1 FUJIFILM Wako Pure Chemical Corporation Corporation Information
12.8.2 FUJIFILM Wako Pure Chemical Corporation Overview
12.8.3 FUJIFILM Wako Pure Chemical Corporation Antiserum Sales, Revenue, Price and Gross Margin (2017-2022)
12.8.4 FUJIFILM Wako Pure Chemical Corporation Antiserum Products and Services
12.8.5 FUJIFILM Wako Pure Chemical Corporation Antiserum SWOT Analysis
12.8.6 FUJIFILM Wako Pure Chemical Corporation Recent Developments
12.9 Thermo Scientific
12.9.1 Thermo Scientific Corporation Information
12.9.2 Thermo Scientific Overview
12.9.3 Thermo Scientific Antiserum Sales, Revenue, Price and Gross Margin (2017-2022)
12.9.4 Thermo Scientific Antiserum Products and Services
12.9.5 Thermo Scientific Antiserum SWOT Analysis
12.9.6 Thermo Scientific Recent Developments
12.10 Bio-Rad
12.10.1 Bio-Rad Corporation Information
12.10.2 Bio-Rad Overview
12.10.3 Bio-Rad Antiserum Sales, Revenue, Price and Gross Margin (2017-2022)
12.10.4 Bio-Rad Antiserum Products and Services
12.10.5 Bio-Rad Antiserum SWOT Analysis
12.10.6 Bio-Rad Recent Developments
13 Value Chain and Sales Channels Analysis
13.1 Antiserum Value Chain Analysis
13.2 Antiserum Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Antiserum Production Mode & Process
13.4 Antiserum Sales and Marketing
13.4.1 Antiserum Sales Channels
13.4.2 Antiserum Distributors
13.5 Antiserum Customers
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Antiserum Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Antitoxin Serum
Table 3. Major Manufacturers of Antibacterial Serum
Table 4. Major Manufacturers of Antiviral Serum
Table 5. Major Manufacturers of Anti-Rh Serum
Table 6. Global Antiserum Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Antiserum Production by Region: 2017 VS 2021 VS 2028 (K MT)
Table 8. Global Antiserum Production by Region (2017-2022) & (K MT)
Table 9. Global Antiserum Production Market Share by Region (2017-2022)
Table 10. Global Antiserum Production by Region (2023-2028) & (K MT)
Table 11. Global Antiserum Production Market Share by Region (2023-2028)
Table 12. Antiserum Market Trends
Table 13. Antiserum Market Drivers
Table 14. Antiserum Market Challenges
Table 15. Antiserum Market Restraints
Table 16. Global Antiserum Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 17. Global Antiserum Sales by Region (2017-2022) & (K MT)
Table 18. Global Antiserum Sales Market Share by Region (2017-2022)
Table 19. Global Antiserum Sales by Region (2023-2028) & (K MT)
Table 20. Global Antiserum Sales Market Share by Region (2023-2028)
Table 21. Global Antiserum Revenue by Region (2017-2022) & (US$ Million)
Table 22. Global Antiserum Revenue Market Share by Region (2017-2022)
Table 23. Global Antiserum Revenue by Region (2023-2028) & (US$ Million)
Table 24. Global Antiserum Revenue Market Share by Region (2023-2028)
Table 25. Global Antiserum Production Capacity by Manufacturers (2017-2022) & (K MT)
Table 26. Global Antiserum Capacity Market Share by Manufacturers (2017-2022)
Table 27. Global Antiserum Production by Manufacturers (2017-2022) & (K MT)
Table 28. Global Antiserum Production Market Share by Manufacturers (2017-2022)
Table 29. Global Antiserum Sales by Manufacturers (2017-2022) & (K MT)
Table 30. Global Antiserum Sales Share by Manufacturers (2017-2022)
Table 31. Global Antiserum Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 32. Global Antiserum Revenue Share by Manufacturers (2017-2022)
Table 33. Antiserum Price by Manufacturers 2017-2022 (USD/MT)
Table 34. Global Antiserum Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Antiserum by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiserum as of 2021)
Table 36. Antiserum Manufacturing Base Distribution and Headquarters
Table 37. Manufacturers Antiserum Product Offered
Table 38. Date of Key Manufacturers Enter into Antiserum Market
Table 39. Mergers & Acquisitions, Expansion Plans
Table 40. Global Antiserum Sales by Type (2017-2022) & (K MT)
Table 41. Global Antiserum Sales by Type (2023-2028) & (K MT)
Table 42. Global Antiserum Sales Share by Type (2017-2022)
Table 43. Global Antiserum Sales Share by Type (2023-2028)
Table 44. Global Antiserum Revenue by Type (2017-2022) & (US$ Million)
Table 45. Global Antiserum Revenue by Type (2023-2028) & (US$ Million)
Table 46. Global Antiserum Revenue Share by Type (2017-2022)
Table 47. Global Antiserum Revenue Share by Type (2023-2028)
Table 48. Antiserum Price by Type (2017-2022) & (USD/MT)
Table 49. Global Antiserum Price Forecast by Type (2023-2028) & (USD/MT)
Table 50. Global Antiserum Sales by Application (2017-2022) & (K MT)
Table 51. Global Antiserum Sales by Application (2023-2028) & (K MT)
Table 52. Global Antiserum Sales Share by Application (2017-2022)
Table 53. Global Antiserum Sales Share by Application (2023-2028)
Table 54. Global Antiserum Revenue by Application (2017-2022) & (US$ Million)
Table 55. Global Antiserum Revenue by Application (2023-2028) & (US$ Million)
Table 56. Global Antiserum Revenue Share by Application (2017-2022)
Table 57. Global Antiserum Revenue Share by Application (2023-2028)
Table 58. Antiserum Price by Application (2017-2022) & (USD/MT)
Table 59. Global Antiserum Price Forecast by Application (2023-2028) & (USD/MT)
Table 60. North America Antiserum Sales by Company (2017-2022) & (K MT)
Table 61. North America Antiserum Sales Market Share by Company (2017-2022)
Table 62. North America Antiserum Revenue by Company (2017-2022) & (US$ Million)
Table 63. North America Antiserum Revenue Market Share by Company (2017-2022)
Table 64. North America Antiserum Sales by Type (2017-2022) & (K MT)
Table 65. North America Antiserum Sales by Type (2023-2028) & (K MT)
Table 66. North America Antiserum Revenue by Type (2017-2022) & (US$ Million)
Table 67. North America Antiserum Revenue by Type (2023-2028) & (US$ Million)
Table 68. North America Antiserum Sales by Application (2017-2022) & (K MT)
Table 69. North America Antiserum Sales by Application (2023-2028) & (K MT)
Table 70. North America Antiserum Revenue by Application (2017-2022) & (US$ Million)
Table 71. North America Antiserum Revenue by Application (2023-2028) & (US$ Million)
Table 72. North America Antiserum Sales by Country (2017-2022) & (K MT)
Table 73. North America Antiserum Sales by Country (2023-2028) & (K MT)
Table 74. North America Antiserum Revenue by Country (2017-2022) & (US$ Million)
Table 75. North America Antiserum Revenue by Country (2023-2028) & (US$ Million)
Table 76. Europe Antiserum Sales by Company (2017-2022) & (K MT)
Table 77. Europe Antiserum Sales Market Share by Company (2017-2022)
Table 78. Europe Antiserum Revenue by Company (2017-2022) & (US$ Million)
Table 79. Europe Antiserum Revenue Market Share by Company (2017-2022)
Table 80. Europe Antiserum Sales by Type (2017-2022) & (K MT)
Table 81. Europe Antiserum Sales by Type (2023-2028) & (K MT)
Table 82. Europe Antiserum Revenue by Type (2017-2022) & (US$ Million)
Table 83. Europe Antiserum Revenue by Type (2023-2028) & (US$ Million)
Table 84. Europe Antiserum Sales by Application (2017-2022) & (K MT)
Table 85. Europe Antiserum Sales by Application (2023-2028) & (K MT)
Table 86. Europe Antiserum Revenue by Application (2017-2022) & (US$ Million)
Table 87. Europe Antiserum Revenue by Application (2023-2028) & (US$ Million)
Table 88. Europe Antiserum Sales by Country (2017-2022) & (K MT)
Table 89. Europe Antiserum Sales by Country (2023-2028) & (K MT)
Table 90. Europe Antiserum Revenue by Country (2017-2022) & (US$ Million)
Table 91. Europe Antiserum Revenue by Country (2023-2028) & (US$ Million)
Table 92. Asia Pacific Antiserum Sales by Company (2017-2022) & (K MT)
Table 93. Asia Pacific Antiserum Sales Market Share by Company (2017-2022)
Table 94. Asia Pacific Antiserum Revenue by Company (2017-2022) & (US$ Million)
Table 95. Asia Pacific Antiserum Revenue Market Share by Company (2017-2022)
Table 96. Asia Pacific Antiserum Sales by Type (2017-2022) & (K MT)
Table 97. Asia Pacific Antiserum Sales by Type (2023-2028) & (K MT)
Table 98. Asia Pacific Antiserum Revenue by Type (2017-2022) & (US$ Million)
Table 99. Asia Pacific Antiserum Revenue by Type (2023-2028) & (US$ Million)
Table 100. Asia Pacific Antiserum Sales by Application (2017-2022) & (K MT)
Table 101. Asia Pacific Antiserum Sales by Application (2023-2028) & (K MT)
Table 102. Asia Pacific Antiserum Revenue by Application (2017-2022) & (US$ Million)
Table 103. Asia Pacific Antiserum Revenue by Application (2023-2028) & (US$ Million)
Table 104. Asia Pacific Antiserum Sales by Region (2017-2022) & (K MT)
Table 105. Asia Pacific Antiserum Sales by Region (2023-2028) & (K MT)
Table 106. Asia Pacific Antiserum Revenue by Region (2017-2022) & (US$ Million)
Table 107. Asia Pacific Antiserum Revenue by Region (2023-2028) & (US$ Million)
Table 108. Latin America Antiserum Sales by Company (2017-2022) & (K MT)
Table 109. Latin America Antiserum Sales Market Share by Company (2017-2022)
Table 110. Latin America Antiserum Revenue by Company (2017-2022) & (US$ Million)
Table 111. Latin America Antiserum Revenue Market Share by Company (2017-2022)
Table 112. Latin America Antiserum Sales by Type (2017-2022) & (K MT)
Table 113. Latin America Antiserum Sales by Type (2023-2028) & (K MT)
Table 114. Latin America Antiserum Revenue by Type (2017-2022) & (US$ Million)
Table 115. Latin America Antiserum Revenue by Type (2023-2028) & (US$ Million)
Table 116. Latin America Antiserum Sales by Application (2017-2022) & (K MT)
Table 117. Latin America Antiserum Sales by Application (2023-2028) & (K MT)
Table 118. Latin America Antiserum Revenue by Application (2017-2022) & (US$ Million)
Table 119. Latin America Antiserum Revenue by Application (2023-2028) & (US$ Million)
Table 120. Latin America Antiserum Sales by Country (2017-2022) & (K MT)
Table 121. Latin America Antiserum Sales by Country (2023-2028) & (K MT)
Table 122. Latin America Antiserum Revenue by Country (2017-2022) & (US$ Million)
Table 123. Latin America Antiserum Revenue by Country (2023-2028) & (US$ Million)
Table 124. Middle East and Africa Antiserum Sales by Company (2017-2022) & (K MT)
Table 125. Middle East and Africa Antiserum Sales Market Share by Company (2017-2022)
Table 126. Middle East and Africa Antiserum Revenue by Company (2017-2022) & (US$ Million)
Table 127. Middle East and Africa Antiserum Revenue Market Share by Company (2017-2022)
Table 128. Middle East and Africa Antiserum Sales by Type (2017-2022) & (K MT)
Table 129. Middle East and Africa Antiserum Sales by Type (2023-2028) & (K MT)
Table 130. Middle East and Africa Antiserum Revenue by Type (2017-2022) & (US$ Million)
Table 131. Middle East and Africa Antiserum Revenue by Type (2023-2028) & (US$ Million)
Table 132. Middle East and Africa Antiserum Sales by Application (2017-2022) & (K MT)
Table 133. Middle East and Africa Antiserum Sales by Application (2023-2028) & (K MT)
Table 134. Middle East and Africa Antiserum Revenue by Application (2017-2022) & (US$ Million)
Table 135. Middle East and Africa Antiserum Revenue by Application (2023-2028) & (US$ Million)
Table 136. Middle East and Africa Antiserum Sales by Country (2017-2022) & (K MT)
Table 137. Middle East and Africa Antiserum Sales by Country (2023-2028) & (K MT)
Table 138. Middle East and Africa Antiserum Revenue by Country (2017-2022) & (US$ Million)
Table 139. Middle East and Africa Antiserum Revenue by Country (2023-2028) & (US$ Million)
Table 140. Charles River Corporation Information
Table 141. Charles River Description and Overview
Table 142. Charles River Antiserum Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 143. Charles River Antiserum Products and Services
Table 144. Charles River Antiserum SWOT Analysis
Table 145. Charles River Recent Development
Table 146. SSI Diagnostica Corporation Information
Table 147. SSI Diagnostica Description and Overview
Table 148. SSI Diagnostica Antiserum Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 149. SSI Diagnostica Antiserum Products and Services
Table 150. SSI Diagnostica Antiserum SWOT Analysis
Table 151. SSI Diagnostica Recent Development
Table 152. BD Corporation Information
Table 153. BD Description and Overview
Table 154. BD Antiserum Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 155. BD Antiserum Products and Services
Table 156. BD Antiserum SWOT Analysis
Table 157. BD Recent Development
Table 158. GD Animal Health Corporation Information
Table 159. GD Animal Health Description and Overview
Table 160. GD Animal Health Antiserum Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 161. GD Animal Health Antiserum Products and Services
Table 162. GD Animal Health Antiserum SWOT Analysis
Table 163. GD Animal Health Recent Development
Table 164. Novacyt Group Corporation Information
Table 165. Novacyt Group Description and Overview
Table 166. Novacyt Group Antiserum Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 167. Novacyt Group Antiserum Products and Services
Table 168. Novacyt Group Antiserum SWOT Analysis
Table 169. Novacyt Group Recent Development
Table 170. OriGene Technologies Corporation Information
Table 171. OriGene Technologies Description and Overview
Table 172. OriGene Technologies Antiserum Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 173. OriGene Technologies Antiserum Products and Services
Table 174. OriGene Technologies Antiserum SWOT Analysis
Table 175. OriGene Technologies Recent Development
Table 176. Bethyl Laboratories Corporation Information
Table 177. Bethyl Laboratories Description and Overview
Table 178. Bethyl Laboratories Antiserum Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 179. Bethyl Laboratories Antiserum Products and Services
Table 180. Bethyl Laboratories Antiserum SWOT Analysis
Table 181. Bethyl Laboratories Recent Development
Table 182. FUJIFILM Wako Pure Chemical Corporation Corporation Information
Table 183. FUJIFILM Wako Pure Chemical Corporation Description and Overview
Table 184. FUJIFILM Wako Pure Chemical Corporation Antiserum Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 185. FUJIFILM Wako Pure Chemical Corporation Antiserum Products and Services
Table 186. FUJIFILM Wako Pure Chemical Corporation Antiserum SWOT Analysis
Table 187. FUJIFILM Wako Pure Chemical Corporation Recent Development
Table 188. Thermo Scientific Corporation Information
Table 189. Thermo Scientific Description and Overview
Table 190. Thermo Scientific Antiserum Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 191. Thermo Scientific Antiserum Products and Services
Table 192. Thermo Scientific Antiserum SWOT Analysis
Table 193. Thermo Scientific Recent Development
Table 194. Bio-Rad Corporation Information
Table 195. Bio-Rad Description and Overview
Table 196. Bio-Rad Antiserum Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 197. Bio-Rad Antiserum Products and Services
Table 198. Bio-Rad Antiserum SWOT Analysis
Table 199. Bio-Rad Recent Development
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Antiserum Distributors List
Table 203. Antiserum Customers List
Table 204. Research Programs/Design for This Report
Table 205. Key Data Information from Secondary Sources
Table 206. Key Data Information from Primary Sources
List of Figures
Figure 1. Antiserum Product Picture
Figure 2. Global Antiserum Market Share by Type in 2021 & 2028
Figure 3. Antitoxin Serum Product Picture
Figure 4. Antibacterial Serum Product Picture
Figure 5. Antiviral Serum Product Picture
Figure 6. Anti-Rh Serum Product Picture
Figure 7. Global Antiserum Market Share by Application in 2021 & 2028
Figure 8. Laboratory
Figure 9. Clinical
Figure 10. Other
Figure 11. Antiserum Report Years Considered
Figure 12. Global Antiserum Capacity, Production and Utilization (2017-2028) & (K MT)
Figure 13. Global Antiserum Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Antiserum Production Market Share by Region (2017-2022)
Figure 15. Global Antiserum Production Market Share by Region (2023-2028)
Figure 16. Antiserum Production Growth Rate in North America (2017-2028) & (K MT)
Figure 17. Antiserum Production Growth Rate in Europe (2017-2028) & (K MT)
Figure 18. Antiserum Production Growth Rate in Japan (2017-2028) & (K MT)
Figure 19. Antiserum Production Growth Rate in China (2017-2028) & (K MT)
Figure 20. Antiserum Production Growth Rate in South Korea (2017-2028) & (K MT)
Figure 21. Antiserum Production Growth Rate in India (2017-2028) & (K MT)
Figure 22. Global Antiserum Sales 2017-2028 (K MT)
Figure 23. Global Antiserum Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 24. Global Antiserum Revenue 2017-2028 (US$ Million)
Figure 25. Global Antiserum Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 26. Global Antiserum Sales Market Share by Region (2017-2022)
Figure 27. Global Antiserum Sales Market Share by Region (2023-2028)
Figure 28. North America Antiserum Sales YoY (2017-2028) & (K MT)
Figure 29. North America Antiserum Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Europe Antiserum Sales YoY (2017-2028) & (K MT)
Figure 31. Europe Antiserum Revenue YoY (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Antiserum Sales YoY (2017-2028) & (K MT)
Figure 33. Asia-Pacific Antiserum Revenue YoY (2017-2028) & (US$ Million)
Figure 34. Latin America Antiserum Sales YoY (2017-2028) & (K MT)
Figure 35. Latin America Antiserum Revenue YoY (2017-2028) & (US$ Million)
Figure 36. Middle East & Africa Antiserum Sales YoY (2017-2028) & (K MT)
Figure 37. Middle East & Africa Antiserum Revenue YoY (2017-2028) & (US$ Million)
Figure 38. The Top 10 and Top 5 Players Market Share by Antiserum Sales in 2021
Figure 39. The Top 10 and Top 5 Players Market Share by Antiserum Revenue in 2021
Figure 40. Antiserum Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 41. Global Antiserum Sales Market Share by Type (2017-2028)
Figure 42. Global Antiserum Revenue Market Share by Type (2017-2028)
Figure 43. Global Antiserum Sales Market Share by Application (2017-2028)
Figure 44. Global Antiserum Revenue Market Share by Application (2017-2028)
Figure 45. North America Antiserum Sales Market Share by Type (2017-2028)
Figure 46. North America Antiserum Revenue Market Share by Type (2017-2028)
Figure 47. North America Antiserum Sales Market Share by Application (2017-2028)
Figure 48. North America Antiserum Revenue Market Share by Application (2017-2028)
Figure 49. North America Antiserum Sales Share by Country
  • Global Alkaline Detergent Market Research Report 2022
    Published: 28-Nov-2022        Price: US 2900 Onwards        Pages: 119
    Highlights The global Alkaline Detergent market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028. North American market for Alkaline Detergent is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. Asia-Pacific market for Alkaline Detergent is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR......
  • Global Neutralizer for Alkaline Cleaner Market Research Report 2022
    Published: 28-Nov-2022        Price: US 2900 Onwards        Pages: 94
    Highlights The global Neutralizer for Alkaline Cleaner market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028. North American market for Neutralizer for Alkaline Cleaner is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. Asia-Pacific market for Neutralizer for Alkaline Cleaner is estimated to increase from $ million in ......
  • Global Neutral Enzyme Cleaner Market Research Report 2022
    Published: 28-Nov-2022        Price: US 2900 Onwards        Pages: 102
    Highlights The global Neutral Enzyme Cleaner market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028. North American market for Neutral Enzyme Cleaner is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. Asia-Pacific market for Neutral Enzyme Cleaner is estimated to increase from $ million in 2022 to reach $ million by 202......
  • Global OLED Intermediates and Crude Monomers Market Research Report 2022
    Published: 28-Nov-2022        Price: US 2900 Onwards        Pages: 90
    Highlights The global OLED Intermediates and Crude Monomers market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028. North American market for OLED Intermediates and Crude Monomers is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. Asia-Pacific market for OLED Intermediates and Crude Monomers is estimated to increase fro......
  • Global Feed Grade Calcium Carbonate Market Research Report 2022
    Published: 28-Nov-2022        Price: US 2900 Onwards        Pages: 94
    Highlights The global Feed Grade Calcium Carbonate market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028. North American market for Feed Grade Calcium Carbonate is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. Asia-Pacific market for Feed Grade Calcium Carbonate is estimated to increase from $ million in 2022 to reac......
  • Global Jewelry 3D Printing Materials Market Research Report 2022
    Published: 28-Nov-2022        Price: US 2900 Onwards        Pages: 86
    Highlights The global Jewelry 3D Printing Materials market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028. North American market for Jewelry 3D Printing Materials is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. Asia-Pacific market for Jewelry 3D Printing Materials is estimated to increase from $ million in 2022 to r......
  • Global Black Phosphorus Powder Market Research Report 2022
    Published: 28-Nov-2022        Price: US 2900 Onwards        Pages: 104
    Compared with other allotropes of phosphorus (white and red phosphorus)‚ black phosphorus powder is a thermodynamic stable semiconductor material. It can be widely used in photo-catalysis‚ photo-degradation‚ and other photo-voltage effects. Highlights The global Black Phosphorus Powder market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028. North American market for Black Phosphorus Powder is estimated to i......
  • Global Boron Nitride Flakes Market Research Report 2022
    Published: 28-Nov-2022        Price: US 2900 Onwards        Pages: 96
    Highlights The global Boron Nitride Flakes market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028. North American market for Boron Nitride Flakes is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. Asia-Pacific market for Boron Nitride Flakes is estimated to increase from $ million in 2022 to reach $ million by 2028, at ......
  • Global Boron-doped Graphene Market Research Report 2022
    Published: 28-Nov-2022        Price: US 2900 Onwards        Pages: 71
    Highlights The global Boron-doped Graphene market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028. North American market for Boron-doped Graphene is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. Asia-Pacific market for Boron-doped Graphene is estimated to increase from $ million in 2022 to reach $ million by 2028, at ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs